Abstract
Purpose: To assess the correlation between intraocular pressure (IOP) levels and retinal ganglion cell (RGC) loss across different fixed-duration episodes of acute ocular hypertension (AOH). Methods: AOH was induced in Thy1-YFP-H transgenic mice by inserting a needle connected to a saline solution container into the anterior chamber. Thirty-one groups were tested, each comprising three to five mice exposed to IOP levels ranging from 50 to 110 mm Hg in 5/10 mm Hg increments for 60/90/120 minutes and a sham control group. The YFP-expressing RGCs were quantified by confocal scanning laser ophthalmoscopy, whereas peripapillary ganglion cell complex thickness was measured using spectral-domain optical coherence tomography. Changes in RGC count and GCCT were determined from values measured 30 days after AOH relative to baseline (before AOH). Results: In the 60-minute AOH groups, RGC loss varied even when IOP was increased up to 110 mm Hg (36.8%–68.2%). However, for longer durations (90 and 120 minutes), a narrow range of IOP levels (60–70 mm Hg for 90-minute duration; 55–65 mm Hg for 120-minute duration) produced a significant difference in RGC loss, ranging from <25% to >90%. Additionally, loss of YFP-expressing RGCs was comparable to that of total RGCs in the same retinas. Conclusions: Reproducible RGC loss during AOH depends on precise durations and IOP thresholds. In the current study, the optimal choice is an AOH protocol set at 70 mm Hg for a duration of 90 minutes. Translational Relevance: This study can assist in determining the optimal duration and intensity of IOP for the effective utilization of AOH models.
Original language | English |
---|---|
Article number | 17 |
Pages (from-to) | 1-11 |
Number of pages | 11 |
Journal | Translational Vision Science and Technology |
Volume | 13 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1 Mar 2024 |
Keywords
- acute ocular hypertension
- duration
- intraocular pressure
- retinal ganglion cell
- yellow fluorescent protein
ASJC Scopus subject areas
- Biomedical Engineering
- Ophthalmology